These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38162671)

  • 21. Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia.
    Ishikawa M; Uemura M; Matsuyama T; Matsumoto M; Ishizashi H; Kato S; Morioka C; Fujimoto M; Kojima H; Yoshiji H; Tsujimoto T; Takimura C; Fujimura Y; Fukui H
    Alcohol Clin Exp Res; 2010 Feb; 34 Suppl 1():S25-33. PubMed ID: 19094193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic liver injury and multiple organ failure.
    Fukui H
    Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):172S-179S. PubMed ID: 16344605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased activity of plasma ADAMTS13 may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.
    Uemura M; Matsuyama T; Ishikawa M; Fujimoto M; Kojima H; Sakurai S; Ishii S; Toyohara M; Yamazaki M; Yoshiji H; Yamao J; Matsumoto M; Ishizashi H; Fujimura Y; Fukui H
    Alcohol Clin Exp Res; 2005 Dec; 29(12 Suppl):264S-71S. PubMed ID: 16385234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Thiamine and Medical Management in Treating Hyperuricemia in AUD Patients with ALD: Role of Hyperuricemia in Liver Injury, Gut-Barrier Dysfunction, and Inflammation.
    Vatsalya V; Li F; Frimodig J; Shah N; Sutrawe A; Feng W
    Clin Exp Pharmacol; 2021; 11(Suppl 7):. PubMed ID: 34522469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The liver is populated by a broad spectrum of markers for macrophages. In alcoholic hepatitis the macrophages are M1 and M2.
    Lee J; French B; Morgan T; French SW
    Exp Mol Pathol; 2014 Feb; 96(1):118-25. PubMed ID: 24145004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-11 drives human and mouse alcohol-related liver disease.
    Effenberger M; Widjaja AA; Grabherr F; Schaefer B; Grander C; Mayr L; Schwaerzler J; Enrich B; Moser P; Fink J; Pedrini A; Jaschke N; Kirchmair A; Pfister A; Hausmann B; Bale R; Putzer D; Zoller H; Schafer S; Pjevac P; Trajanoski Z; Oberhuber G; Adolph T; Cook S; Tilg H
    Gut; 2023 Jan; 72(1):168-179. PubMed ID: 35365572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitis.
    Li W; Xia Y; Yang J; Sanyal AJ; Shah VH; Chalasani NP; Yu Q
    medRxiv; 2023 Dec; ():. PubMed ID: 38168393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease.
    Addolorato G; Ponziani FR; Dionisi T; Mosoni C; Vassallo GA; Sestito L; Petito V; Picca A; Marzetti E; Tarli C; Mirijello A; Zocco MA; Lopetuso LR; Antonelli M; Rando MM; Paroni Sterbini F; Posteraro B; Sanguinetti M; Gasbarrini A
    Liver Int; 2020 Apr; 40(4):878-888. PubMed ID: 31951082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging Pharmacotherapies in Alcohol-Associated Hepatitis.
    Wakil A; Niazi M; Meybodi MA; Pyrsopoulos NT
    J Clin Exp Hepatol; 2023; 13(1):116-126. PubMed ID: 36647403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis.
    Artru F; Bou Saleh M; Maggiotto F; Lassailly G; Ningarhari M; Demaret J; Ntandja-Wandji LC; Pais de Barros JP; Labreuche J; Drumez E; Helou DG; Dharancy S; Gantier E; Périanin A; Chollet-Martin S; Bataller R; Mathurin P; Dubuquoy L; Louvet A
    J Hepatol; 2020 Jun; 72(6):1052-1061. PubMed ID: 31953139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in severe alcoholic liver injury. Nara Liver Study Group.
    Fujimoto M; Uemura M; Kojima H; Ishii Y; Ann T; Sakurai S; Okuda K; Noguchi R; Adachi S; Kitano H; Hoppo K; Higashino T; Takaya A; Fukui H
    Alcohol Clin Exp Res; 1999 Apr; 23(4 Suppl):33S-38S. PubMed ID: 10235276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis.
    Puri P; Liangpunsakul S; Christensen JE; Shah VH; Kamath PS; Gores GJ; Walker S; Comerford M; Katz B; Borst A; Yu Q; Kumar DP; Mirshahi F; Radaeva S; Chalasani NP; Crabb DW; Sanyal AJ;
    Hepatology; 2018 Apr; 67(4):1284-1302. PubMed ID: 29083504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lifetime drinking history in patients with alcoholic liver disease and patients with alcohol use disorder without liver disease.
    Nielsen JK; Olafsson S; Bergmann OM; Runarsdottir V; Hansdottir I; Sigurdardottir R; Björnsson ES
    Scand J Gastroenterol; 2017; 52(6-7):762-767. PubMed ID: 28276826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol-Associated Hepatitis.
    Musto JA; Eickhoff J; Ventura-Cots M; Abraldes JG; Bosques-Padilla F; Verna EC; Brown RS; Vargas V; Altamirano J; Caballería J; Shawcross D; Louvet A; Mathurin P; Garcia-Tsao G; Schnabl B; Bataller R; Lucey MR
    Liver Transpl; 2021 Oct; 27(10):1382-1391. PubMed ID: 34109723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NLRP6 exerts a protective role via NF-kB with involvement of CCL20 in a mouse model of alcoholic hepatitis.
    Ji X; Li L; Lu P; Li X; Tian D; Liu M
    Biochem Biophys Res Commun; 2020 Jul; 528(3):485-492. PubMed ID: 32507279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Medical Treatment for Alcohol-Associated Liver Disease.
    Ayares G; Idalsoaga F; Díaz LA; Arnold J; Arab JP
    J Clin Exp Hepatol; 2022; 12(5):1333-1348. PubMed ID: 36157148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential Activation of Unconventional T Cells, Including iNKT Cells, in Alcohol-Related Liver Disease.
    Marrero I; Maricic I; Morgan TR; Stolz AA; Schnabl B; Liu ZX; Tsukamoto H; Kumar V
    Alcohol Clin Exp Res; 2020 May; 44(5):1061-1074. PubMed ID: 32154597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment retention in a specialized alcohol programme after an episode of alcoholic hepatitis: Impact on alcohol relapse.
    López-Pelayo H; Miquel L; Altamirano J; Bataller R; Caballeria J; Ortega L; Lligoña A; Gual A
    J Psychosom Res; 2019 Jan; 116():75-82. PubMed ID: 30654998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower Serum Magnesium Concentrations are associated With Specific Heavy Drinking Markers, Pro-Inflammatory Response and Early-Stage Alcohol-associated Liver Injury§.
    Vatsalya V; Gala KS; Mishra M; Schwandt ML; Umhau J; Cave MC; Parajuli D; Ramchandani VA; McClain CJ
    Alcohol Alcohol; 2020 Mar; 55(2):164-170. PubMed ID: 32047901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between circulating inflammatory molecules and alcoholic liver disease in men.
    Qu BG; Bi W; Jia YG; Liu YX; Wang H; Su JL; Liu LL; Wang ZD; Wang YF; Han XH; Pan JD; Ren GY; Hu WJ
    Cell Stress Chaperones; 2016 Sep; 21(5):865-72. PubMed ID: 27329162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.